BackBioPlus Acquisition - Units (1 Ord Share Class A & 1/2 War) Overview
BioPlus Acquisition Corp - Units (1 Ord Share Class A & 1/2 War)

BioPlus Acquisition - Units (1 Ord Share Class A & 1/2 War) Return on Equity

Valuation check: BIOSU's ROE is 9.72%, above the sector sector average of -4.47%.

Get informed when a big investor buys or sells

+ Follow

ROE

9.72%

Return on Equity

9.72%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

Average ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

BioPlus Acquisition - Units (1 Ord Share Class A & 1/2 War) (BIOSU) FAQ

The latest ROE for BIOSU is 9.72%. That is above the sector sector average of -4.47%. Investors often review this figure alongside BioPlus Acquisition - Units (1 Ord Share Class A & 1/2 War)'s historical trend and sector peers before judging valuation or financial health.

Against its sector companies, BIOSU currently prints 9.72% for ROE, while the sector average sits near -4.47%. That is roughly 317.6% above the sector mean. Large gaps often invite a closer look at BioPlus Acquisition - Units (1 Ord Share Class A & 1/2 War)'s growth, margins, and balance sheet.

Return on Equity shows how effectively BioPlus Acquisition - Units (1 Ord Share Class A & 1/2 War) converts resources into returns. At 9.72%, BIOSU may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting BIOSU's ROE (9.72%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.